Leveraging the power of the human microbiome for a healthier life.

Developing better therapies through a deep understanding of human microbial ecology

Siolta Therapeutics is a clinical-stage biopharmaceutical company developing targeted live biotherapeutic products to prevent and treat diseases of high unmet medical need. By leveraging our proprietary Precision Symbiotics Platform™ and in-house GMP-manufacturing capabilities, we are rapidly expanding our product pipeline into new indications with multiple programs in preclinical and clinical-stage development.